ANTARES PHARMA, INC.: key financial figures for fiscal year 2021 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2021)

$184.0M

Net Income/Loss (FY2021)

$46.3M

Total Assets (FY2021)

$257.5M

Total Equity (FY2021)

$175.8M

Cash Flows from Operating Activities (FY2021)

$36.6M

Source: ANTARES PHARMA, INC. 10-K filing (FY2021). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.